| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5823044 | Antiviral Research | 2007 | 7 Pages |
Abstract
RNAi is capable of inhibiting HBV replication and expression in vitro and in vivo and thus may constitute a new therapeutic strategy for HBV infection.
Related Topics
Life Sciences
Immunology and Microbiology
Virology
Authors
Ruo-Su Ying, Cai Zhu, Xue-Gong Fan, Ning Li, Xue-Fei Tian, Hong-Bo Liu, Bao-Xin Zhang,